Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Katie Doores and Jonathan Edgeworth.
Connection Strength

1.429
  1. Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave. PLoS One. 2021; 16(4):e0249791.
    View in: PubMed
    Score: 0.235
  2. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 12; 5(12):1598-1607.
    View in: PubMed
    Score: 0.227
  3. Translational Research in the Time of COVID-19-Dissolving Boundaries. PLoS Pathog. 2020 09; 16(9):e1008898.
    View in: PubMed
    Score: 0.226
  4. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020 09; 16(9):e1008817.
    View in: PubMed
    Score: 0.226
  5. Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 Aug 21; 145(16):5638-5646.
    View in: PubMed
    Score: 0.223
  6. Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission. Clin Microbiol Infect. 2022 Jan; 28(1):93-100.
    View in: PubMed
    Score: 0.060
  7. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study. Lancet Microbe. 2021 Sep; 2(9):e461-e471.
    View in: PubMed
    Score: 0.060
  8. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021 06 07; 12(1):3406.
    View in: PubMed
    Score: 0.059
  9. Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 Oct; 26(10):1663.
    View in: PubMed
    Score: 0.057
  10. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 10; 26(10):1623-1635.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.